We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis.
- Authors
Soriano, María Cruz; Narváez-Chávez, Gabriela; López-Olivencia, Marina; Fortún, Jesús; de Pablo, Raúl
- Abstract
Dear Editor, Recently, Prattes and colleagues [[1]] published in Intensive Care Medicine a high incidence of coronavirus disease 2019-associated invasive pulmonary aspergillosis (CAPA), according to 2020 ECMM/ISHAM consensus criteria [[2]], with a correspondingly high mortality rate. 1 CAPA diagnosis from August 2020 to June 2021 We conclude that the application of a set of increased environmental protective measures and supplementary inhaled ABCL should be considered to control an outbreak of CAPA in mechanically ventilated patients with COVID-19.
- Subjects
PULMONARY aspergillosis; AMPHOTERICIN B; PREVENTIVE medicine; COVID-19
- Publication
Intensive Care Medicine, 2022, Vol 48, Issue 3, p360
- ISSN
0342-4642
- Publication type
Letter
- DOI
10.1007/s00134-021-06603-y